1313359-28-2

Basic information

• Product Name: tert-butyl methyl(4-(4-fluoroquinolin-2-yl)phenyl)carbamate
• Synonyms: tert-butyl methyl(4-(4-fluoroquinolin-2-yl)phenyl)carbamate
• CAS NO: 1313359-28-2
• Molecular Weight: 352.408
• Mol File: 1313359-28-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl methyl(4-(4-fluoroquinolin-2-yl)phenyl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl methyl(4-(4-fluoroquinolin-2-yl)phenyl)carbamate(1313359-28-2)
• EPA Substance Registry System: tert-butyl methyl(4-(4-fluoroquinolin-2-yl)phenyl)carbamate(1313359-28-2)

Safety Data

• Hazardous Substances Data: 1313359-28-2(Hazardous Substances Data)

Upstream product

• 1246093-98-0 tert-butyl methyl(4-(4-nitroquinolin-2-yl)phenyl)carbamate 
• 20146-63-8 2-bromo-4-nitroquinoline 
• 56-57-5 4-nitroquinoline-N-oxide 

Downstream Products

• 1246092-06-7 4-(4-fluoroquinolin-2-yl)-N-methylaniline 

Relevant articles and documents

For detecting imaging agent of neurological disorders

Imaging agents of formulas (I)-(V) and methods for detecting neurological disorders comprising administering to a patient in need compounds of formulas (I)-(V) capable of binding to tau proteins and β-amyloid peptides are presented herein. The invention also relates to methods of imaging Aβ and tau aggregates comprising introducing a detectable quantity of pharmaceutical formulation comprising a radiolabeled compound of formulas (I)-(V) and detecting the labeled compound associated with amyloid deposits and/or tau proteins in a patient. These methods and compositions enable preclinical diagnosis and monitoring progression of AD and other neurological disorders.